ShareSoc Webinar with Silence Therapeutics (SLN)
11 November 2020

Company: Silence Therapeutics (SLN) Date: 11th November 2020 Time: 5pm - 6pm Presenter: Mark Rothera, President and CEO Format: Webinar Company Information: Silence Therapeutics is developing a new generation of medicines by harnessing the body’s natural mechanism of RNA interference, or RNAi, to inhibit the expression of specific target genes thought to play a role in the pathology of diseases with significant unmet medical need. Silence’s proprietary technology can be used to engineer short interfering ribonucleic acids (siRNAs) that bind specifically to and silence, through the RNAi ...